Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.
A 24-kDa recombinant protein from Trypanosoma cruzi (rTc24) was evaluated by enzyme-linked immunosorbent assay (ELISA) and Western blot (immunoblot) tests to identify treated chagasic patients considered parasitologically cured on the basis of persistently negative tests of hemocultures and lytic an...
Salvato in:
| Pubblicato in: | J Clin Microbiol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1995
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC228340/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7559953/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.33.8.2086-2090.1995 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
